tepotinib hydrochloride monohydrate

Spain

Drugs containing this active substance

  • TEPMETKO 225 MG FILM-COATED TABLETS

    It is used to treat adults with lung cancer that has spread to other parts of the body or cannot be removed by surgery, provided that the tumor cells have a MET gene alteration and previous treatments have not worked.

    Form: tablets, film-coated

    Active substance Dosage
    tepotinib hydrochloride monohydrate 250 mg

    ATC: L01E L01EP L01EP02

    Manufacturer: Merck Europe B.V.